Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Horsman

Showing results (71-80 of 106) with videos related to

Pageof 11
Sort By:
International Journal of Radiation Biology|March 1, 1991
Structure-activity relationships for tumour radiosensitization by analogues of nicotinamide and benzamideJ M Brown, M J Lemmon, M R Horsman, et al.
British Journal of Cancer|February 1, 1986
Changes in the response of the RIF-1 tumour to melphalan in vivo induced by inhibitors of nuclear ADP-ribosyl transferaseM R Horsman, D M Brown, D G Hirst, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 1993
Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapyM R Horsman, M Høyer, D J Honess, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
Cisplatin and hyperthermia treatment of a C3H mammary carcinoma in vivo. Importance of sequence, interval, drug dose, and temperatureJ C Lindegaard, M Radacic, A A Khalil, et al.
British Journal of Cancer|January 1, 1997
The effect of hypoxia and hyperoxia on nucleoside triphosphate/inorganic phosphate, pO2 and radiation response in an experimental tumour modelM Nordsmark, R J Maxwell, M R Horsman, et al.
British Journal of Cancer|August 1, 1996
DNA damage and repair in tumour and non-tumour tissues of mice induced by nicotinamideA R Olsson, Y Sheng, R W Pero, et al.
Biomedica Biochimica Acta|January 1, 1989
Mechanism for the reduction of tumour hypoxia by nicotinamide and the clinical relevance for radiotherapyM R Horsman, J Overgaard, K L Christensen, et al.
Acta Oncologica (Stockholm, Sweden)|November 28, 2000
Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucoseL Bentzen, S Keiding, M R Horsman, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
Effects of combretastatin on murine tumours monitored by 31P MRS, 1H MRS and 1H MRIR J Maxwell, F U Nielsen, T Breidahl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 1990
The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivoM R Horsman, P J Wood, D J Chaplin, et al.
Pageof 11

Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Biology|March 1, 1991
Structure-activity relationships for tumour radiosensitization by analogues of nicotinamide and benzamideJ M Brown, M J Lemmon, M R Horsman, et al.
British Journal of Cancer|February 1, 1986
Changes in the response of the RIF-1 tumour to melphalan in vivo induced by inhibitors of nuclear ADP-ribosyl transferaseM R Horsman, D M Brown, D G Hirst, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 1993
Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapyM R Horsman, M Høyer, D J Honess, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
Cisplatin and hyperthermia treatment of a C3H mammary carcinoma in vivo. Importance of sequence, interval, drug dose, and temperatureJ C Lindegaard, M Radacic, A A Khalil, et al.
British Journal of Cancer|January 1, 1997
The effect of hypoxia and hyperoxia on nucleoside triphosphate/inorganic phosphate, pO2 and radiation response in an experimental tumour modelM Nordsmark, R J Maxwell, M R Horsman, et al.
British Journal of Cancer|August 1, 1996
DNA damage and repair in tumour and non-tumour tissues of mice induced by nicotinamideA R Olsson, Y Sheng, R W Pero, et al.
Biomedica Biochimica Acta|January 1, 1989
Mechanism for the reduction of tumour hypoxia by nicotinamide and the clinical relevance for radiotherapyM R Horsman, J Overgaard, K L Christensen, et al.
Acta Oncologica (Stockholm, Sweden)|November 28, 2000
Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucoseL Bentzen, S Keiding, M R Horsman, et al.
International Journal of Radiation Oncology, Biology, Physics|December 9, 1998
Effects of combretastatin on murine tumours monitored by 31P MRS, 1H MRS and 1H MRIR J Maxwell, F U Nielsen, T Breidahl, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 1990
The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivoM R Horsman, P J Wood, D J Chaplin, et al.
Pageof 11